Overview

This trial is active, not recruiting.

Conditions disorder of bone density and structure, unspecified, satisfaction
Treatments dexa: dual energy x-ray absorptiometry, short form health survey 12, vas-satisfaction, vas-pain, harris hip score
Sponsor Rijnstate Hospital
Start date January 2014
End date January 2016
Trial size 20 participants
Trial identifier NCT02061904, BMD&BIG

Summary

Prospective explorative study for the investigation of short-term and medium-term outcomes regarding bone mineral density changes after revision hip arthroplasty making use of bone impaction grafting. Outcome measurements will include objective and subjective clinical data, complications and adverse events, radiographic data measurements recorded at several postoperative intervals.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Intervention model single group assignment
Masking open label
Primary purpose diagnostic
Arm
(Other)
Bone mineral density measurement with "intervention" DEXA at the bone impaction graft site: DEXA: dual energy X-ray absorptiometry
dexa: dual energy x-ray absorptiometry Bone Mineral Density measurement
Bone mineral density development measured with dual energy X-ray absorptiometry
(Other)
Hip Function/mobility development: Harris Hip Score
harris hip score HHS
questionnaire for hip function monitoring
(Other)
Pain experiences after surgery in the hip joint VAS-pain
vas-pain visual analog scale for pain
questionnaire for pain monitoring
(Other)
Patients health condition monitoring: intervention SF12: Short Form Health Survey 12
short form health survey 12 SF12
questionnaire for general health monitoring
(Other)
Patients satisfaction development after the intervention VAS-satisfaction
vas-satisfaction Visual analoge Scale for satisfaction.
questionnaire for intervention satisfaction monitoring

Primary Outcomes

Measure
Bone mineral density changes
time frame: 24 months

Eligibility Criteria

Male or female participants from 35 years up to 75 years old.

Inclusion Criteria: 1. revision hip arthroplasty with acetabular defects eligible for bone impaction grafting 2. Diagnosis: acetabular osteolytic defects after primary total hip arthroplasty, planned for revision hip arthroplasty with bone impaction grafting. 3. Patient is between 35 and 75 years old. 4. Patient is expected to recover completely. 5. Patient is willing and able to come to follow-up examinations. 6. Patient has signed an informed consent. Exclusion Criteria: 1. Infection of the hip joint or distant infection (may cause hematogenous spread to the implant site) 2. Hip fractures 3. Patient is younger than 35 years or older than 75 years. 4. Patient is not willing and/or able to come to follow-up examinations 5. Patient has not signed an informed consent 6. Pregnancy Relative contra-indications: With regard to the patient's general health: 1. Metabolic disorders or medication (e.g. steroids) which may impair bone formation 2. Osteomalacia 3. Disorders of the immune system, caused by disease or immunosuppressive medication which increase the risk of infection. 4. Poor prognosis for good wound healing: decubitus ulcer, end-stage diabetes, severe protein deficiency and/or malnutrition

Additional Information

Official title Prospective Exploratory Study:Bone Mineral Density Changes of the Acetabulum After Revision Hip Arthroplasty Using Bone Impaction Grafting
Principal investigator J v Susante, MD. PhD
Description Hypothesis, open questions and specific aims of the project: We believe that it is important to gain further insight in the process of bone graft remodeling and the preservation of bone stock after bone impaction grafting. Radiographs are far from conclusive and CT scan can not be repeated on regular intervals for obvious reasons. Prospective follow-up of the BMD of the bone impaction area will contribute to our further understanding. There is no literature available on BMD changes in the acetabulum after bone impaction grafting. From our recent experiences with earlier research on BMD in specific ROI in the femoral neck we are motivated to further explore the potential of our DEXA technology and software in the field revision hip arthroplasty. We hypothesize that BMD changes in the bone impaction grafted acetabulum can be adequately monitored with modern DEXA techniques. Research Questions are: 1. Will bone impaction grafting of the acetabulum result in a well preserved/remodelled bone stock within 2 years after revision hip arthroplasty? 2. Can changes in BMD be interpreted as representative for the process of bone remodelling in the bone impacted area? Study design This trial as described in this protocol is a prospective explorative follow-up study recording the clinical, radiographic data, and bone mineral density data at specific time intervals (preoperative, within 2 weeks postoperative, at 3months, 6months, 1 year and 2 years postoperative). The data will be collected using SPSS (version 20.) Main objective: To prospectively assess the BMD at short and medium time intervals in specific ROI as an indicator for the process of bone remodelling and ossification of the bone impaction graft after revision hip arthroplasty.. Secondary Objectives: Clinical scores (SF-12, Oxford Hip score, VAS pain and VAS satisfaction) will be obtained. Vigilant identification of Adverse Events (AEs) will be maintained throughout the study. Mean changes in clinical scores, over time, will also be tested with repeated measurement statistics. Because clinical success is not always indicative of radiographic success and vice versa, correlations will be made. Sample size: Our study concerns an explorative study in twenty patients. Study duration: The expected duration of the study is approximately 3 years from the commencement of subject enrollment. Subject enrollment is expected to take 1 year. All subjects will be followed for at least two years after surgery until the last subject achieves two-years follow-up. Evaluation criteria The study is designed to evaluate possible clinical, radiographic and bone densitometry differences changes after revision hip arthroplasty. Evaluation criteria at different follow-up intervals. A Clinical: - the patient's own evaluation according to the Oxford Score, Dutch translation validated - the patient's evaluation of his general health with the SF-12 score , license to validated Dutch translation11 - the patient's degree of pain and satisfaction with the prosthesis and the procedure. B Radiological: - X-ray evaluations of implant stability, migration, changing of cup or head angles, radiolucent lines, loosening and osteolysis. X-Rays should preferably be digital, at preoperative, 6 months, 1 year and 2 years. C. DEXA bone density measurements - Bone density measurements will be performed preoperative on the acetabulum on several regions of interests (ROI's) including the bone impaction grafting area. Once this ROI's of the acetabulum has been determined it can be digitalized and saved into the software, subsequently this ROI can be transported 4 days postoperative and at 4 days postoperative, 6 months, 1 year and 2 years. - This method has been tested in our earlier resurfacing study and has proved to be reliable and reproducable. - An independent radiologist will do the measurements on the DEXA-scan D Survival after revision hip arthroplasty with bone impaction grafting - According to Kaplan Meiers survival rates. E Complications and adverse events - Early and late complications possibly associated with revision hip arthroplasty and possible relationship with bone impaction grafting and surgical technique.
Trial information was received from ClinicalTrials.gov and was last updated in July 2016.
Information provided to ClinicalTrials.gov by Rijnstate Hospital.